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Abstract
Spatial models for disease mapping should ideally account for covariates measured both at individ-
ual and area levels. The newly available “indiCAR” model fits the popular conditional autoregresssive
(CAR) model by accommodating both individual and group level covariates while adjusting for spatial
correlation in the disease rates. This algorithm has been shown to be effective but assumes log-linear
associations between individual level covariates and outcome. In many studies, the relationship be-
tween individual level covariates and the outcome may be non-loglinear, and methods to track such
non-linearity between individual level covariate and outcome in spatial regression modeling are not well
developed. In this paper, we propose a new algorithm, smooth-indiCAR, to fit an extension to the pop-
ular conditional autoregresssive model which can accommodate both linear and non-linear individual
level covariate effects while adjusting for group level covariates and spatial correlation in the disease
rates. In this formulation the effect of a continuous individual level covariate is accommodated via pe-
nalized splines. We describe a two-step estimation procedure to obtain reliable estimates of individual
and group level covariate effects where both individual and group level covariate effects are estimated
separately. This distributed computing framework enhances its application in the Big Data domain with
a large number of individual/group level covariates. We evaluate the performance of smooth-indiCAR
through simulation. Our results indicate that the smooth-indiCAR method provides reliable estimates of
all regression and random effect parameters. We illustrate our proposed methodology with an analysis
of data on neutropenia admissions in New South Wales (NSW), Australia.
1 Introduction
The rapid growth of Geographic Information Systems (GIS) together with the advances in high perfor-
mance computing environments, presents a unique opportunity to examine the relationship between risk
factors and outcomes that vary across geographical locations. Careful analysis of spatial data can lead
to useful explanation of the exposure and disease relationship through natural experimentation where in-
dividuals (or clusters of individuals) exposed to the experimental and control conditions are determined
by nature or by other factors outside the control of the investigators, but the process governing the expo-
sures arguably resembles random assignment (33; 31). It also helps in understanding the spatial variation
of disease, disease clustering, distribution of socio-demographic characteristics, environmental exposure
distribution and its impact on health outcomes (9).
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Analysis of spatially indexed data is complicated by correlations among neighboring observations (6;
3; 7). Regression analysis which ignores this spatial correlation may lead to incorrect inference on the
estimated regression coefficients due to the narrowing of associated confidence intervals (35). Mixed
effects models provide a convenient way of adjusting for spatial correlation by incorporating spatially
defined random effects in the model, with the most commonly used approach being the conditionally
autoregressive (CAR) model (5; 21). Using such models allows us to map disease rates by borrowing
information about each small area from its surrounding areas, leading to more stable estimation. The use
of CAR-based random effects within a hierarchical generalized linear model offers a robust, flexible, and
enormously popular class of models for the exploration and analysis incorporating small area rates for
disease mapping.
In the case study that motivates this paper, researchers from the New South Wales (NSW) Cancer
Institute were interested in exploring the geographical variation of neutropenia admissions across NSW,
Australia. Neutropenia is a life threatening complication of cancer chemotherapy and a major cause of
morbidity and associated health care resource costs. Geographical variations in neutropenia admissions
are of particular interest because of non-uniform health care services across NSW resulting from uneven
population concentration (2). Moreover, neutropenia experiences for each patient might also depend on
their age and cancer type, as treatment modalities often vary across different types of cancer and age groups.
Therefore, appropriate analysis of geographical variation of neutropenia admissions requires adjustment of
both patient demographic characteristics and covariates reflecting patients geographic location of residence.
Exploratory analysis reveals a non-linear association between the observed neutropenia rates and patient
age. The non-linear age effect has also been noted in many previous studies (30; 24). While the theory
has been developed for CAR models with smooth group level covariates (22), there is a lack of algorithms
to fit smooth individual level covariates for CAR models. The glmm function in mgcv package in R offers
functionality to fit an AR(1) model, but there no software to accommodate both nonlinear individual and
group level covariate effects while adjusting for more general spatial structure.
Recently, Huque et al. proposed an individual level covariate adjusted CAR (indiCAR) model which
can incorporate both individual and area level covariates while adjusting for spatial random effects (16).
Although this approach is very useful in modeling a large number of individual and group level covariate
effects, it relies on an assumption of log-linear dependence between the expected value of the outcome
and covariates. In many epidemiological study settings, such linearity of the covariate effect may not be
appropriate and instead other types of non-linearity may be in operation. For example, maternal age has
a non-linear effect on gestational age (18). Although transformation of variable is a well-known approach
for handling non-linearity in regression model, often transformation is not known or may not be adequate
to induce linearity (32). In our case, commonly available square root or log transformation of age was
inadequate to induce linearity suggesting a need to use spline based techniques for modeling the effect of
covariates in a flexible non-linear fashion .
Therefore, in our current study we extend the indiCAR method (16) to incoprporate smooth non-linear
covariate effect using penalized splines, termed as smooth-indiCAR. This additional sets of penalized
splines in the indiCAR method requires solution of a Double Penalized Quasi-Likelihood (DPQL) equation
involving both individual and group level data in order to obtain an estimate of the regression coefficients.
However, no software/algorithms are currently available. Following indiCAR, we incorporate individual
level smooth covariate information in a two-step iterative procedure following an initialization step. In
this method, the individual level and the group level covariate effects are fitted in separate iterations by
appropriate calculation of an offset at each step. We illustrate that the estimation and inference based
on smooth-indiCAR can be carried out in a distributed computing framework, thus achieving a helpful
reduction in computational cost and memory requirements.
We evaluate the performance of the smooth-indiCAR method through simulation studies. Our results
show that the smooth-indiCAR is able to correctly estimate coefficients associated with both individual
and group-level covariates. We further illustrate this method through the analysis of data on neutropenia
admissions from the NSW Cancer Institute and conclude with some practical guidelines.
The structure of the paper is as follows: Section 2 describes the data set. Model formulation and
estimation procedure are given in section 3. Section 4 describes the inference procedure. Data generation
process for our simulations and results using simulated data are presented in section 5. An application of
the proposed method to data on neutropenia is given in section 6. We conclude with general discussion in
section 7.
2
2 Data
Our study population comprises all cancer patients that were diagnosed with cancer and were hospitalized
in NSW, Australia during the period between 2001 and 2009. Data from the NSW Central Cancer Registry,
linked to the NSW Admitted Patient Data Collection, were used to identify patients diagnosed with cancer
and their associated treatment procedures and co-morbidities. Detailed descriptions of the data items can be
obtained from the Centre for Health Record Linkage (CHeReL http://www.cherel.org.au/ master-linkage-
key). Data were checked for consistency across data sources and linked by assigning a unique Project
Person Number to each patient.
Demographic variables including age at diagnosis, gender, residence at diagnosis, postal area of resi-
dence, and Accessibility/Remoteness Index of Australia (ARIA) based on patient residence were obtained
from the Central Cancer Registry database. The ARIA variable was recorded at individual level rather
than postal area level because the ARIA index varies within postal area. The Socio Economic Index For
Areas (SEIFA; an index of social disadvantage) and the geo-coded shape files for mapping corresponding
to 2006 census postal areas were obtained from the Australian Bureau of Statistics. Individual level clinical
characteristics such as type of cancer were also obtained from Central Cancer Registry. The diagnosis of
neutropenia admission and co-morbidity were obtained using data from the Admitted Patients Data Col-
lection. The ICD-10-AM (International Statistical Classification of Disease and Related Health problems,
10th revision, Australian modification) code D70 (Agranulocytosis) was used to identify admissions with
possible neutropenia.
3 Statistical model
Suppose the study area is divided into M contiguous regions and the number of neutropenia admis-
sions for the ith (i = 1, 2, ..., nj) individual in the jth (j = 1, 2, ...,M) area is denoted by {yij}. Let
Y = (y11, y21, ..., yn11, ..., y1j , y2j ..., ynjj , ..., y1M , y2M , ..., ynMM )
T be a vector with elements {yij}
that represent the number of admissions for each individual in the study regions of interest. Similarly,
letX = (X1, X2, ..., Xp) and U = (U1, U2, ..., Uq) represent individual and area level covariate matrices
with dimensions n×p andM×q, respectively, where n is the total sample size i.e., n = ∑Mj=1 nj . Further
suppose that in addition to the log-linear relationship of X and U with Y , an additional individual level
covariate, T exhibits a non-linear relationship with with the expectation of Y . Under the above specifica-
tions, conditional on the area specific random effect vector, b, the number of events for each cancer patient
is assumed to be Poisson distributed with mean µ where
ln(µ) = Xβ + f(T ) +ZUγ +Zb. (1)
Here, β is a p × 1 vector of regression coefficients associated with the individual level covariates, f(T )
is an unknown smooth function, γ is a q × 1 vector of area-specific regression coefficients and Z =
blockdiag(Z1, Z2, ..., ZM ) is a replication matrix that replicates group level covariates and random effects
to the individual level, whereZj is a vector of length nj with all elements equal to 1. We further assume that
the unknown smooth function f(T ) can be represented by a linear combination of spline basis functions,
i.e., f(T ) = BT(T )ν. HereB(T ) is a vector of spline basis functions and ν is a vector of corresponding
basis coefficients. For simplicity in exposition we have only include a single non-linear covariate effect,
however, the proposed method can be generalized to the case when more than one non-linear covariate
effects is susceptible.
Note that the proposed model (1) represents various study designs, such as clustered, hierarchical and
spatial designs depending on the specification of the random effect b. For example, the random effect may
represent specification for a) random slope and intercept for the multilevel (hierarchical) models (11), b)
random intercept and stochastic process as of longitudinal studies (40) and c) modeling spatial correlation
in disease mapping (21). Throughout this paper we will focus on modeling random effects so that they re-
flect spatial correlation. Our postulated model (1) is an extension of (22) that incorporates individual level
predictors and area specific conditional auto-regressive random effects in the context of disease mapping
literature.
To fit model (1), many different choices of random effects, b are available in the mapping literature
(see (20) for a recent review). Among these, the method of Leroux el al. is appealing because it allows
for a weighted combination of spatially structured and unstructured area-level variation (21). Within this
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framework, the random effect vector, b has a multivariate normal distribution with mean 0 and a covariance
matrix,D with Moore-Penrose generalized inverse,D− = σ−2{(1− λ)I + λR}, where I is the identity
matrix andR is the intrinsic auto-regression matrix reflecting neighborhood structure. Typically, neighbors
are those areas which share a common boundary. The typical element ofR is given by
Rjj′ =
{
mj , j = j
′
−I{j ∼ j′} j 6= j′,
where, mj is the number of neighbors of region j, and I{j ∼ j′} is an indicator function that takes value
1 if regions j and j′ are neighbors and 0 otherwise. Alternatively, a distance based neighborhood structure
could be used (8). The parameters characterizing the random effect distribution, θ = (σ2 > 0, λ ∈ [0, 1])
quantify over-dispersion and spatial dependence, respectively. A larger value of λ ∈ [0, 1] indicates a
higher degree of spatial dependence. This specification results in two extreme cases: i) completely inde-
pendent random effects when λ = 0 and ii) the intrinsic auto-regressive model when λ = 1 (3). In general,
a weighted combination of these two extreme (spatial independence and strong spatial dependence) is
assumed (21).
Inference about β, γ and θ for model (1) can be made by integrating out or averaging over the dis-
tribution of the unobserved random effects, b when there are no non-linear predictors in model (1). The
corresponding integrated quasi-likelihood function is equal to (see equation (2) of (5))
|D|− 12
∫
exp
−1
2
M∑
j=1
nj∑
i=1
dij(Yij , µij)− 1
2
bTD−b
 db,
where d(Y,µ) is the deviance residual.
The maximum quasi-likelihood estimates of β, γ, and θ are those values of β, γ and θ that maximize
the above quasi-likelihood. However, no simple closed form solution exists. Instead, (5) proposed the
penalized quasi-likelihood (PQL) approach for parameter estimation and inference. The PQL uses the
Laplace method for integral approximation and jointly maximizes the above quasi-likelihood function to
obtain estimates for β, γ and b(θ).
In the presence of a non-linear predictor, however, statistical inference about β, γ and θ must account
for the estimation of the basis coefficient, ν and smoothing parameter δ (say). (22) showed that approx-
imate estimates of the regression parameters β, γ, θ and ν can be obtained by maximizing the following
Double Penalized Quasi-Likelihood equation with respect to β, γ, b and ν :
−1
2
M∑
j=1
nj∑
i=1
dij(Yij , µij)− 1
2
bTD−b− 1
2
νTSν, (2)
where S = δK with smoothing parameter δ and penalty matrix K. Here, K is a (q + N) × (q + N)
matrix where q is the number of knots and N is the dimension of the unpenalized function. Given the knot
locations {x∗(k) : k = 1, 2, ..., q}, the penalty matrix has zeros everywhere except in its lower right q × q
block with K(ik) = ‖x∗j(i) − x∗j(k)‖3, for k ≤ q. The penalty matrices map the spline basis functions to
the data whereas the penalty parameters control the amount of smoothing (32; 37). For now, assume that
the smoothing parameter δ is known.
Under the above specification the approximate log likelihood can be expressed as
const+ Y T(Xβ +BT(T )ν +ZUγ +Zb)−
1T exp(Xβ +BT(T )ν +ZUγ +Zb)− 1
2
bTD−b− 1
2
νTSν, (3)
where 1T = (1, 1, ..., 1), is a vector of 1’s. Differentiating (3) with respect to β, ν, γ and b using vector
matrix calculus (36), we obtain the following score equations{
Y − exp(Xβ +BT(T )ν +ZUγ +Zb)
}T
X = 0, (4)
{
Y − exp(Xβ +BT(T )ν +ZUγ +Zb)
}T
B(T ) = νTS, (5)
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{
Y − exp(Xβ +BT(T )ν +ZUγ +Zb)
}T
ZU = 0, (6)
and {
Y − exp(Xβ +BT(T )ν +ZUγ +Zb)
}T
Z = bTD−. (7)
In principle, Penalized Iteratively Re-weighted Least Squares (P-IRLS) can be applied to solve the
above equations for β, ν, γ and θ (37). However, lack of available software along with high computational
costs and memory space constraints make it difficult to apply these iterative procedures to data sets with
a large number of group level covariates and a large sample size. An alternative computational strategy
is the use of the Gauss-Seidel algorithm to obtain the same estimates of the associated parameters as can
be obtained by P-IRLS (13). In this approach, at each iteration one of the parameters is estimated while
keeping others fixed at current values. Within this framework, we first initialize β and ν and then obtain
updated estimates for γ and θ in the following two step procedure:
Step 0: To initialize, set the coefficients of area level covariates, γ and random effects, b to zero in
equation (4) and (5). Then we have{
Y − exp(Xβ +BT(T )ν)
}T
X = 0,
and, {
Y − exp(Xβ +BT(T )ν)
}T
B(T ) = νTS.
If the value of penalty parameter δ is known, the solution of the above equations can be computed by a
penalized version of the iterative re-weighted least square method used for GLM estimation (37; 12). The
smoothing parameter can be estimated using the Generalized Cross Validation score (GCV) or the general-
ized Akaike’s Information Criterion (37). Computationally, the estimation of the regression parameters ν
associated with non-linear function and smoothing parameter δ can be obtain using a penalized splines ap-
proach with the existing gam function in the mgcv package (37) inR (28). Thus we can obtain an estimate
of the regression coefficients β and ν associated with individual level covariates and the penalty parameter
δ. Although these parameters can also be estimated using penalized splines (P-splines/ B-splines) tech-
niques, such an approach require careful selection of the number of knots and knot location. Instead gam
function in the mgcv package uses thin plate regression splines as the default choice which doesn’t require
the estimation of knot locations and are computationally efficient. The choice of the number of knots (basis
dimensions for the thin plate regression splines) is not generally critical for thin-plate regression splines as
long as this is large enough to represents the degrees of freedom of the underlying true model.
This step provides initial estimates of the regression coefficients β and ν.
Step 1. Now substitute the current estimated individual level coefficients, β̂ and ν̂ into equations (6)
and (7). With some simple algebra, we have
{Y c − exp(O1 +Uγ + b)}TU = 0
and,
{Y c − exp(O1 +Uγ + b)}T = bTD−,
where, Y Tc = Y
TZ, is a vector of aggregated outcome counts of length M at the group level and O1 =
log{ZT exp(Xβ̂ +BT(T )ν̂)} is a vector of offsets.
The above two equations are well known PQL estimating equations associated with the Poisson mixed
model (5). Since, the outcomeY c, offset O1, covariateU and random effects b are all available at the group
level, estimates of parameters for the group level coefficient γ̂ and random effects θ can be estimated using
the existing PQL method (5; 21) with only group level data. This results in substantial computational
savings.
Step 2. Substitute the estimated area-specific regression coefficient, γ̂ and random effect parameter, θ̂
estimated at Step 1 into (4) & (5). With some simple algebra, we have{
Y − exp(O2 +Xβ +BT(T )ν)
}T
X = 0,
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and {
Y − exp(O2 +Xβ +BT(T )ν)
}T
B(T ) = νTS,
where O2 = Z(Uγ̂+b̂) is a offset vector of dimension n×1. Under the above specification, the individual
level coefficient estimates β̂ and ν̂ and smoothing parameter δ can then be updated using the gam function
with individual level data.
Step 1 and 2 are then repeated until the algorithm converges. The estimated coefficients and random
effect parameters obtained by this iterative procedure will be similar (aside from rounding error) to the
estimates of the true regression coefficients and random effect parameters which would be obtained by
solving equations (3) - (7) directly.
4 Inference
Model fitting at Step 1 and Step 2 assumes fixed (β,ν) and fixed γ, respectively. Therefore the correspond-
ing standard errors of (β,ν) obtained from gam and (γ, θ) obtained from the PQL method based on Step
2 and Step 1 will not be exactly correct. We re-calculate the standard error of these regression coefficients
by adjusting the estimated standard errors of β̂, γ̂ and ν̂. This can be done via the IRLS estimation based
on score equations (4, 5, 6 and 7) for a known smoothing parameter, δ (22). The IRLS estimation requires
us to define a working dependent variable and a weight matrix that are updated at each iteration and solved
via Fisher scoring (5; 37).
Now assume that an unpenalized linear combination of basis functions is adequate to represent the
nonlinear function f(T ). In this case the linear combination of the basis functions contributes to the log-
likelihood equation (3) via the fixed effect components only. Hence the model (1) can be represented
by a more general model, in which the conditional mean vector µ is modeled via a log-link function as
η = ln(µ) = Xβ+B(T )ν+ZUγ+Zb and can be estimated using the PQL approach. The PQL fitting
approach requires calculation of the GLM adjusted dependent variable Y pseudo = η̂+ (Y − µ̂) δη̂δµ̂ at each
step of the iteration (26). The GLM adjusted dependent variable , Y pseudo corresponding to (1) is given
by
Y pseudo = Xβ +B(T )ν +ZUγ +Zb+W
−1(Y − µ) (8)
where W is a n× n diagonal matrix with diagonal term µ. Following (14) and (29), it can be shown that
the Fisher scoring corresponding to the score equations (4, 5, 6 and 7) and GLM dependent variable as in
(8), is identical to the normal equation of the best linear unbiased predictors (BLUPs) of β, γ, ν and θ
corresponding to the following linear mixed model
Y pseudo = Xβ +B(T )ν +ZUγ +Zb+ pseudo,
where the pseudo-error, pseudo is normally distributed with mean 0 and covariance matrix W−1. The
estimated regression coefficients for the fixed effect, (β,γ,ν) and BLUP estimate for the random effect b
can be obtained as (29)
(β̂, γ̂, ν̂) = (CTV −1C)−1(CTV −1Y pseudo)
and
b̂ = DZTV −1{Y −Xβ̂ −ZUγ̂ −B(T )ν̂}, (9)
where C = [X|ZU |B(T )] is a design matrix consisting of the individual level covariate matrix, group
level covariates and basis functions, and V = ZDZT+W−1 is the variance of pseudo response Y pseudo.
Now consider the fact that the nonlinear function f(T ) is represented using spline regression bases,
with associated roughness penalties in the log-likelihood equation (3). Following (37) and (25), it can be
shown that the maximum penalized likelihood estimate, (β̂, γ̂ and ν̂) can be obtained as
(β̂, γ̂, ν̂) = (CTV −1C + S1)−1(CTV −1Y pseudo)
b̂ = DZTV −1{Y −Xβ̂ −ZUγ̂ −B(T )ν̂}, (10)
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where S1 is the smooth matrix consisting of 0s except in the block corresponding to the basis coefficients
ν, where it is replaced by smoothing matrix S. Thus, the frequentist variance-covariance matrix for the
fixed effect (β̂, γ̂ and ν̂) can be estimated by
QFreq = (C
TV −1C + S1)−1CTV −1C(CTV −1C + S1)−1. (11)
However, (37) noted that the above estimated standard error for non-parametric functions is only useful
when testing basis coefficients which are equal to zero. He also suggests the use of an alternative Bayesian
approach to calculate uncertainty, which results in a Bayesian posterior covariance matrix for the parame-
ters as
QBayes = (C
TV −1C + S1)−1. (12)
Note that the above frequentist and the Bayesian estimates of standard error differ in the inference about
basis coefficients, but are virtually identical for linear individual and group level covariate effects. Further
note that reliable estimates of the regression coefficients and variance components can also be obtained
using the model of (22) with appropriate specification of the design matrix (Z) associated with the spatial
random effect model (1). However, their formulation requires the representation of smooth terms as a
linear combination of fixed and random effect covariates. Back-fitting approaches such as the smooth-
indiCAR method calculate the tuning parameters at Step 1 and will be effective in situations where memory
constraints prohibit the fitting of a single model consisting of a large numbers of individual and group level
covariates. Smooth-indiCAR not only provides a convenient way of fitting large numbers of individual
and group level covariates in a distributed computing framework, it also allows us to calculate the standard
error in a distributed computing framework. This is because V −1 can be expressed as W −WZD(I +
ZTWZD)−1ZTW (15). Therefore, the above Bayesian variance-covariance matrix can be written as
Q =
((
a11 a12
a21 a22
)
+ S1
)−1
,
where,
a11 = X¯
T
WX¯ − X¯TWZD(I +ZTWZD)−1 ×ZTWX¯
a12 = X¯
T
WZU − X¯TWZD(I +ZTWZD)−1 ×ZTWZU
a21 = a
T
12
a22 = U
TZTWZU −UTZTWZD × (I +ZTWZD)−1ZTWZU .
Here X¯ = [X|B(T )], is the design matrix combining individual level covariates and basis functions.
Thus, among the various components of the above variance-covariance matrix, X¯TWX¯ and X¯TWZ
are the only terms involving individual level data, and the rest of the terms involve a lower dimension
corresponding to the group level data. Hence, upon convergence, calculation of the variance covariance
matrix can also be carried out in a distributed computing framework for individual and group-level data
separately.
However, the above standard errors for the non-linear function, f(T ) rely heavily on the large sample
assumption and treating the smoothing parameter as a known quantity (37). In reality, the smoothing
parameter is estimated from the data, hence the confidence intervals for the non-linear function based on
the standard errors as calculated above may not be appropriate. (25) proposed and developed an alternative
confidence interval based on the above frequentist and Bayesian variance-covariance matrices. In this
formulation the Bayesian and frequentist confidence intervals for the non-linear function, f(T ) can be
obtained as f̂(T ) ± zα/2
√
[V f ]ii, where f̂(T ) = BT(T )ν̂, V f = B(T )V νBT(T ), and zα/2 is the
critical value of the standard normal distribution with level of significance, α. Here, V ν is the variance
covariance matrix of ν̂ that can be obtained from the corresponding blocks ofQFreq in (11) and ofQBayes
in (12) in order to obtain frequentist and Bayesian confidence intervals, respectively. These confidence
intervals are known to exhibit good coverage probabilities (39). In this paper, we have presented the
smooth-indiCAR approach as a method of adjusting for a non-linear covariate term within our model.
Here, the non-linear term is considered as a confounding variable, and the main interest lies in inference
on other model parameters. More detailed analysis of this non-linear term, such as formally testing for
equality to zero, is beyond the scope of this paper.
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The covariance matrix for θ̂ was obtained from the Fisher information matrix from Step 1 in the usual
way, assuming that the parameters for the individual and area specific covariates are fixed. Of course
there is additional variability due to the fact that the individual and area specific covariate parameters are
estimated. However, following (5) we ignore the additional variability due to estimation of γ̂ and β̂ for
inference about estimated random effect parameter, θ̂. Further details are given in Appendix A.
In the next section we describe a simulation study to evaluate the performance of the smooth-indiCAR
method.
5 Simulation study
To evaluate our proposed smooth-indiCAR approach, we design a simulation study involving 400 regions
in a 20 × 20 square lattice grid with varying sample sizes. To evaluate the smooth-indiCAR in both a
large and a smaller sample setting, we divided a total of 20000 individuals (scenario i) and 5000 individ-
uals (scenario ii) randomly among 400 areas. In this allocation, we ensured that each region contained
at least one individual. We define two regions as neighbors if they share a common border. The random
effects are then generated following a multivariate normal distribution with mean 0 and covariance matrix
D = [σ−2 {(1− λ)I + λR}]−1. The value of σ is set to 0.4 and five different values of spatial depen-
dence parameters, λ = {0, 0.25, 0.50, 0.75, 0.99} are considered in order to represent different strengths
of spatial correlation ranging from the independent case (no spatial correlation, λ = 0, to a very high
spatial correlation, λ = 0.99). We then generate three individual level covariates (one binary, one cate-
gorical and one continuous) and one group level covariate. The binary covariate represents the distribution
of sex in the area and is generated following a Bernoulli random variable with probability ranging from
0.45 to 0.55 across groups. The categorical variable with five categories is generated with pre-specified
probabilities. The continuous individual level covariate, T is generated using a univariate bump function as
f(t) = 11+t − 2e−20(t−1)
2
, to represent an age effect. The group level covariate is generated as a standard
normal random variable. The outcome variable is then generated using model (1). The overall intercept of
the model is set to zero in this simulation. This is because the overall intercept parameters of the model is
not identifiable in the presence of non-linear function using mgcv package in R, as the current implemen-
tation assumes non-linear function decomposed into the intercept and linear combination of basis function
(25). The full list of the parameters used to generate the simulated data is given in the header row of Table
1.
5.1 Simulation Results
Table 1 displays the average of the estimated regression coefficients for the linear individual level covari-
ates (βs), group level covariate (γ) and parameters in the spatial random effects (σ and λ) corresponding to
model (1) along with their estimated standard errors based on 500 simulation runs of scenario (i) with var-
ious specification of the spatial random effect. We calculate two different standard errors for the estimated
regression coefficients: namely, (a) empirical standard errors i.e., taking the standard deviation of the 500
simulated regression coefficient estimates, (b) average of model based standard errors. The first column of
Table 1 specifies the spatial dependence parameter (λ) used in that particular simulation. The second col-
umn represents the estimated coefficients corresponding to the binary variable, the next four columns list
the estimated regression coefficients for the categorical individual level covariates. The last three columns
list the estimated regression coefficients for the group specific covariate, estimated over-dispersion param-
eter and spatial dependence parameter. The true and estimated non-linear curves associated with scenario
(i) were presented in Figure 1. The solid line represents the true non-linear curve and the dotted lines rep-
resent the estimated non-linear functions from the first 50 simulations. Only the first 50 simulations were
plotted to enhance the visibility of each estimated graph around the true curve.
As expected, the smooth-indiCAR method provides reliable estimates of the individual level and region
specific regression coefficients and the spatial random effect parameters in all of the spatial dependence
settings considered. In general, the average of the estimated regression and random effect coefficients
matches well with the true value of the coefficients used in the simulation study. Moreover, the estimated
standard error matches well with the empirical standard error for the individual level and region specific
regression coefficients. However, there is a slight underestimation of the standard errors for the spatial
random effect parameters. The estimated non-linear functions also approximate the true non-linear function
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well (Figure 1) while the variability of the fitted curve increases with the degree of the spatial dependence
parameter.
To evaluate the performance of the proposed method in a small sample setting, we also conducted an-
other simulation study with 5000 subjects distributed randomly in 400 regions (scenario (ii)). The estimates
of the regression coefficients are given in Table 2. The true and estimated non-linear curves associated with
scenario (ii) are given in Figure 2. As indicated in the Table 2 and Figure 2, the proposed method also per-
forms well in the case when the number of individuals in a group is low.
We have also compared the computational time between the smooth-indiCAR and a generalized addi-
tive mixed model with cluster specific random intercept using mgcv package in R (37). Data were generated
using two different spatial correlation parameters, λ = 0, which means that a random intercept only model
is appropriate and λ = 0.75, which means that a CAR component is necessary for an accurate model
fit. Varying sample sizes are considered both in 100 and 400 regions. One hundred simulation datasets
were generated and fitted using smooth-indiCAR and GAMM with random intercept. The median com-
putational time between these two approaches are presented in Table 4. It is clear for the table that in the
case of both independent and spatially correlated data the GAMM with random intercept model is faster
when the number of subjects within each group is low. However, with the increase of number of subjects
within each group the smooth-indiCAR outperform the GAMM with random intercept model in terms of
computational time.
6 Application to the neutropenia data
One of the key objectives of this analysis is to assess the geographical variation of neutropenia admission
rates and its association with area level measures of socio-economic status. Data also includes patient
age, gender, year of diagnosis, ARIA, cancer types at diagnosis, number of major comorbidities other than
cancer and geographic location reported via postcode of residence. The descriptive data on the patients
characteristics are given in the web Appendix Table 5. Briefly, data were collected from 279,623 cancer
patients who received chemotherapy in NSW between 2001 and 2009. Among them only 4.5% were
diagnosed with neutropenia. Exploratory analysis of our data using categorized values of age (not shown)
suggested a non-linear association between age and the risk of chemotherapy-induced neutropenia. Indeed
a plot of the predicted smooth curve and associated confidence bounds obtained by our method confirm
this (see Figure 3), showing a sharp decline in neutropenia rates beyond age 65. We explored the use of
transformation based approaches such as taking the log or square root of age instead (details obtainable
from authors on request). However, none of these were able to adequately capture the pattern present in
the data.
Table 3 reports the multivariable analysis of neutropenia admissions using the smooth-indiCAR and
indiCAR method (16). The key difference between these two approaches is that the former includes a
smooth term to capture non-linear age effect and the latter includes the age effect as linear (misspecified
age effect). In general, the results are quite similar although the magnitude of the regression coefficients
differ. The stronger effect for male, hematological malignant, and patients with higher co-morbidities
as observed in smooth-indiCAR over the indiCAR might reflect the differences in age profile of patients
across various categories of these covariates. Further analysis of neutropenia data using age as a categorical
variable also exhibit very similar results as of smooth-indiCAR (result not shown). Thus smooth-indiCAR
adequately captures the non-linear age effect as difference in estimates are captured more strongly in this
approach compared with the indiCAR approach. Therefore, we believe the addition of a smooth non-linear
term is a worthwhile and valuable extension of the indiCAR as modeling age as a categorical/linear variable
might not represent the relationship as accurately. Moreover, categorization of age is often challenging as
this may introduce residual confounding effect and result in spurious relationships between age and the
outcome variable (31).
We also calculate standardized incidence ratios (SIR) corresponding to each postcode by dividing the
observed number of neutropenia admissions to the model based expected number of neutropenia admis-
sions (4). Figure 4 shows the distribution of estimated SIR following smooth-indiCAR and indiCAR
approaches. We obtained similar distributions of estimated SIR of neutropenia admissions in NSW for the
smooth-indiCAR method and indiCAR method. The strong spatial correlation after adjusting for indi-
vidual and group specific covariates indicates that geographical variation of neutropenia might be due to
differences in health care practices or access to care across NSW.
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7 Discussion
In this paper, we have developed a framework to semi-parametrically adjust for a non-linear individual level
covariate effect in spatial disease mapping. Our results suggest that smooth-indiCAR provides reliable
estimates of the true regression parameters. One of the key advantage of the smooth-indiCAR approach
is that this method can easily be adopted to situation where more than one non-linear covariate effect
might be susceptible. This is due to the fact that the implementation of non-linear function in the smooth-
indiCAR relies on the the existing gam function in the mgcv package which can readily accommodate
more than one smooth terms. Moreover, this method has potential for Big Data implementations due to the
natural applicability of the smooth-indiCAR method in a distributed computing framework . One of the
key problems in Big Data analysis is to divide the data so that this division retains the inherent correlation
structure of the data. Our proposed methodology provides a convenient way for such division by separating
data according to the natural characteristics of the data, based on individual and group level covariates. The
individual level covariate data can then be analyzed with the recent development of generalized additive
models for large data sets (38). Thus our proposed smooth-indiCAR provides a convenient way to extend
recent developments in Big Data for independent responses to the spatially correlated responses. This
could also speed up the process and reduce computational costs.
Although the software implementation is quite similar between indiCAR and smooth-indiCAR except
for the fact that the generalized linear model and the generalized additive model are required to fit the
individual level data for indiCAR and smooth-indiCAR, respectively, the two approaches differ by the
fact that smooth-indiCAR can incorporate the smooth function in the model to characterize the non-linear
covariate effects. The inclusion of the smooth function in the model requires a solution of a double pe-
nalized quasi-likelihood equation. As a result the estimation of the regression parameters using these two
approaches are quite different and current indiCAR algorithm is unable to handle this additional complex-
ity. To obtain a solution of the double penalized quasi-likelihood equation, (22) suggested a mixed model
based approach, however no software is currently available to adopt their approach. Therefore, without the
theoretical development presented in this paper it was not straightforward to incorporate smooth-individual
level covariates in the existing indiCAR model.
Health registries routinely collect geo-coded information for patient’s residence at diagnosis and their
individual level socio-demographic and clinical characteristics and thus could benefit by using our pro-
posed method to incorporate individual level information in the analysis and mapping of disease rates.
We illustrated the proposed approaches using the analysis of neutropenia data. By accounting for both
individual-level and area-level effects, our model would represent an improvement on any analysis which
focused on just one of these. The ability to incorporate individual level covariates in the disease mapping
models provides an additional opportunity to investigate causal relationships without getting caught in the
web of ecological fallacy (34). In our case we however do not have the individual level measurement of
socio-economic status to estimate the true causal effect of individual socio-economic status on the neu-
tropenia rates. Additional study that collect both individual and area level measures of exposure might
provide better insights in regards to the ecological fallacy benefit of the smooth-indiCAR.
Likewise, accounting for age in a non-linear manner is likely to provide a better insight into age ef-
fects that appear to contradict conventional wisdom to some extent (e.g. increasing age appears to have
a declining risk for neutropenia). Since we have the descriptive data indicating this relationship and our
model is clearly able to capture the effect, this would clearly be a potential improvement over modeling age
as a categorical variable which might not represent the relationship as accurately. Additional simulation
suggests non-convergence of group level and random effect parameters when true non-linear covariates is
misspecified as a categorical variable (results not shown in a table). Further confirmation of these results
would need future research. There are also a number of areas where future study would be useful.
In our simulation study we note that we have slightly underestimated the spatial random effect pa-
rameters within our model. This is not a direct limitation of our smooth-indiCAR method, but instead a
symptom of the limitations of the PQL approach when fitting spatial models with small expected counts
(21). In most applications, including our neutropenia study, this bias is small when compared to the em-
pirical standard deviation. However, we note that in cases where very small counts are present, such as the
study of rare diseases, it may be more appropriate to adopt alternative inferential techniques such as a fully
Bayesian approach (20).
In our application to the neutropenia admission data, we observed a lower risk of neutropenia admis-
sions associated with increasing age, although advanced age has been identified as a significant predictor
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for neutropenia admissions in previous studies (19). This might be due to the fact that the current risk
based prophylactic administration of Colony Stimulating Factor guidelines account for patients advanced
age (1). The lower than expected counts near the borders of NSW are almost certainly a result of some pa-
tients being admitted to hospitals in neighboring states. Therefore, the presence of edge effect is inevitable
regardless of the choice of model. As from the map it is clear that the edge effect is mostly presented
near the major metropolitan cities where better access to care is available. Without access to neutropenia
data from these state, the edge effect cannot be fully ascertained. Although adjacency based weight matrix
might influence edge effect but this is still the most commonly used weight matrix for spatial modelling.
Various methods of calculation of weight matrix has been proposed in the literature (8), thus can be em-
ployed to explore in detailed. However, exploration of edge effect based on different weight matrices is
beyond the scope of the present paper. We also identified that both the main regions with higher than
expected counts are located in areas of higher population, and this pattern invites further investigation.
The dependence between area-specific neutropenia rates on ARIA and SEIFA are in the opposite di-
rection. This is counter intuitive as remote areas in NSW are mostly associated with disadvantaged SEIFA
categories. However, the observed contrast in estimated regression coefficients might be due to differences
in the health care practices. Patients in the remote areas where the patients are geographically distant to
the treating medical oncologist are best managed by their primary care physicians, and therefore may be
treated with lower doses of chemotherapy (10). On the contrary, patients in the major cities might get in-
tensive chemotherapy to treat them early, and are better managed due to availability of resources. Previous
studies also indicate that remoteness has the greatest effect in quality of cancer treatment (17) and it affects
treatment choices made by both patients and clinicians (27).
In our application, we observed a very high spatial dependence parameter estimate, λˆ, despite that fact
that we adjust for both individual and group level covariates in our analysis. In order to help explain the
estimation of the high spatial autocorrelation parameter, following the reviewer suggestion, we considered
an additional simulation study using the NSW as the geography consisting of 600 postcodes. A sample
of 20000 subjects were considered for this simulation study. The results are very similar to that presented
in Section 5 and are provided in Appendix Table 6. Although there are some variability in the estimated
spatial regression parameters, the result suggests that the smooth-indiCAR method can adequately estimate
the spatial dependence parameters in accordance with the strength of spatial correlation in the simulated
data. The strong spatial correlation after adjusting for individual and group specific covariates as obtained
from our neutropenia data analysis might indicates that geographical variation of neutropenia might be
due other factors such as differences in health care practices, patients preferences or access to care across
NSW. However, we do not have any data that measure these differences to examine this. Of note, (16)
also reported similar estimates of the spatial dependence parameters following (21) approach that does not
include individual level covariates.
Variation with respect to clinical practices in the treatment of neutropenia has been identified in Aus-
tralia in a previous survey (23). This survey showed that the treatment approach for management of neu-
tropenia varies across oncologists, hematologists and clinicians as well as different sectors of cancer care.
Therefore, it might be interesting to explore whether the observed variation is due to variation across differ-
ent hospitals (eg., metropolitan hospital vs. Non-metropolitan hospitals) in NSW or across various health
care providers. However, data items for such analysis are not collected in the registry and are beyond the
scope of our present paper.
Smooth-indiCAR is a useful addition to the existing methodology to explore clinical variation across
geographical locations where covariates might have non-linear effects. One of the major advantages of our
proposed method is the ability to obtain both individual and group level covariate effects when employing
spatial regression models for disease mapping.
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(a) λ = 0 (b) λ = 0.50
(c) λ = 0.75 (d) λ = 0.99
Figure 1: Fitted nonlinear curves based on first 50 simulations under scenario (i) with different values of
spatial dependence parameter. The solid line indicates true curve.
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(a) λ = 0 (b) λ = 0.50
(c) λ = 0.75 (d) λ = 0.99
Figure 2: Fitted nonlinear curves based on first 50 simulations under scenario (ii). The solid line indicates
true curve.
Figure 3: The estimated effect of age on neutropenia admission rates with associated 95 % Bayesian (light
gray region) and frequentist (dark region) confidence intervals.
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(a) Smooth-indiCAR. (b) indiCAR.
Figure 4: Distributions of estimated Standardized Incidence Ratios of neutropenia admissions in NSW,
Australia following (a) smooth-indiCAR (b) indiCAR.
16
Table 1: Estimated regression coefficients and variance parameters for the proposed smooth-indiCAR
method using simulation scenario (i).
True β2 β32 β33 β34 β35 γ σ λ
value -2.00 -1.50 0.15 0.50 0.20 0.20 0.40
λ Estimated coefficient
0.00 -2.000 -1.499 0.150 0.501 0.201 0.198 0.391 0.021
0.25 -2.001 -1.499 0.150 0.500 0.200 0.197 0.392 0.249
0.50 -1.999 -1.500 0.149 0.499 0.199 0.198 0.392 0.496
0.75 -2.000 -1.499 0.150 0.500 0.202 0.200 0.391 0.723
0.99 -2.000 -1.502 0.147 0.497 0.197 0.198 0.392 0.932
Empirical standard error
0.00 0.020 0.053 0.030 0.028 0.029 0.023 0.036 0.035
0.25 0.020 0.053 0.030 0.029 0.030 0.018 0.041 0.133
0.50 0.020 0.055 0.031 0.028 0.029 0.016 0.042 0.189
0.75 0.020 0.052 0.032 0.029 0.030 0.015 0.034 0.164
0.99 0.020 0.053 0.032 0.031 0.030 0.014 0.024 0.066
Average of the simulated standard error
0.00 0.020 0.052 0.030 0.028 0.029 0.021 0.030 0.049
0.25 0.020 0.053 0.030 0.029 0.029 0.018 0.031 0.095
0.50 0.020 0.053 0.030 0.029 0.029 0.016 0.027 0.113
0.75 0.020 0.053 0.030 0.029 0.029 0.015 0.023 0.099
0.99 0.020 0.054 0.030 0.029 0.029 0.014 0.021 0.046
Table 2: Estimated regression coefficients and variance parameters for the proposed smooth-indiCAR
method using simulation scenario (ii).
True β2 β32 β33 β34 β35 γ σ λ
value -2.00 -1.50 0.15 0.50 0.20 0.20 0.40
λ Estimated coefficient
0.00 -1.999 -1.499 0.151 0.500 0.199 0.197 0.379 0.021
0.25 -1.999 -1.494 0.154 0.504 0.203 0.197 0.371 0.207
0.50 -2.000 -1.495 0.156 0.506 0.208 0.199 0.372 0.403
0.75 -2.004 -1.511 0.153 0.503 0.203 0.199 0.371 0.619
0.99 -2.004 -1.499 0.154 0.503 0.205 0.200 0.391 0.901
Empirical standard error
0.00 0.040 0.107 0.059 0.058 0.059 0.026 0.045 0.039
0.25 0.040 0.104 0.063 0.060 0.059 0.025 0.048 0.141
0.50 0.039 0.110 0.063 0.058 0.060 0.021 0.043 0.167
0.75 0.040 0.110 0.062 0.058 0.061 0.021 0.039 0.178
0.99 0.038 0.107 0.062 0.059 0.060 0.018 0.035 0.108
Average of the simulated standard error
0.00 0.040 0.106 0.061 0.058 0.059 0.025 0.040 0.070
0.25 0.040 0.107 0.062 0.059 0.060 0.022 0.041 0.127
0.50 0.040 0.108 0.062 0.059 0.060 0.021 0.037 0.161
0.75 0.040 0.108 0.062 0.059 0.060 0.020 0.033 0.154
0.99 0.040 0.108 0.062 0.059 0.060 0.019 0.032 0.067
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Table 3: Comparison of estimated regression coefficients and variance parameters of smooth-indiCAR and
indiCAR using neutropenia data.
smooth-indiCAR indiCAR
Regression coefficients Estimates Std. Error Estimates Std. Error
Intercept non-identifiable -1.493 0.047
Sex
Female Ref Ref
Male -0.091 0.020 -0.043 0.020
Age see Figure 3 -0.027 0.001
Year of Diagnosis
2001 Ref Ref
2002 0.016 0.038 0.021 0.038
2003 0.083 0.038 0.083 0.038
2004 0.023 0.038 0.019 0.038
2005 0.097 0.037 0.095 0.037
2006 0.038 0.038 0.038 0.038
2007 0.029 0.038 -0.022 0.038
2008 0.000 0.038 -0.004 0.038
2009 -0.313 0.042 -0.315 0.042
ARIA
Major Cities Ref Ref
Inner Regional Australia -0.024 0.047 -0.006 0.022
Outer Regional Australia -0.150 0.068 -0.118 0.037
Remote/ Very remote Australia -0.244 0.163 -0.192 0.142
Cancer Type
Breast Cancer Ref Ref
Lung cancer 0.259 0.038 0.240 0.037
Colon & rectum cancer -0.428 0.040 -0.463 0.040
Haematological Malignancy 1.579 0.029 1.497 0.029
Other cancer -0.934 0.032 -0.986 0.031
No. of major comorbidities
0 Ref Ref
1 0.424 0.026 0.413 0.026
2 0.680 0.026 0.682 0.026
3 0.625 0.036 0.589 0.036
4+ 0.623 0.035 0.594 0.035
SEIFA
Most disadvantaged Ref Ref
2 -0.082 0.044 -0.089 0.043
3 -0.070 0.041 -0.078 0.038
4 -0.125 0.047 -0.134 0.045
Least disadvantaged -0.129 0.056 -0.144 0.053
Variance parameter
σ 0.203 0.022 0.209 0.022
λ 0.992 0.012 0.992 0.012
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Table 4: Comparison of estimated time (in seconds) when data are generated with varying spatial random
effect parameter, λ and sample sizes.
Time to convergence (in seconds)
λ = 0.0 λ = 0.75
Number Total Smooth- GAMM with Relative time Smooth- GAMM with Relative time
of groups sample indiCAR random intercept indiCAR random intercept
(T1) (T2) T1/T2 (T3) (T4) T3/T4
100 20000 22.4 14.8 1.5 22.3 15.8 1.4
50000 53.0 43.2 1.2 52.7 42.6 1.2
100000 98.5 116.1 0.8 106.2 122.4 0.9
200000 203.7 521.1 0.4 122.8 372.4 0.3
400 20000 35.6 13.9 2.6 24.6 13.4 1.8
50000 45.9 35.2 1.3 44.3 35.0 1.3
100000 80.8 76.3 0.1 76.9 74.5 1.0
200000 211.8 185.7 1.1 215.1 182.9 1.2
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Appendix (Supplementary Materials)
Appendix A: Implementation of PQL in Step 2
The PQL estimation procedure is an iterative approach where at each step one must define a working
dependent variable and a weight matrix which are then updated at each iteration and solved via Fisher
scoring (5; 21). The detailed procedure has been illustrated elsewhere (5; 21).
The GLM adjusted dependent variable (Y c−pseudo) at the group level is calculated as
Y c−pseudo = ηˆc + (Y c − µˆc)
dηˆc
dµˆc
. (13)
Here, ηc = g(µc) = O1 + Uγ + b and O1 = Z
T log{exp(Xβ̂ + BT(T )ν̂)} is an offset vector with
dimension M × 1. The Poisson link g(µc) = logµc and variance function V (µc) = µc are used. The
covariance matrix of Y c−pseudo is then approximated by
V̂c = Ŵc
−1
+ D̂, (14)
where Dˆ is the covariance matrix of the random effects, b, evaluated at the current estimate for the variance
parameters, and Wˆc is the M ×M diagonal matrix with diagonal terms w = µˆc. Updated estimates of the
fixed effect vector γ and random effect vector b are then obtained from the solution of the following mixed
model equations:
γ̂ = (UTV̂c
−1
U)−1U V̂c
−1
(Y c−pseudo − O1), (15)
and
b̂ = DˆV̂c
−1
(Y c−pseudo − O1 −Uγ̂). (16)
The updated estimates of the variance parameters, λ and σ are obtained by a Newton-Raphson iterative
procedure as follows: (
σ̂
λ̂
)updated
=
(
σ̂
λ̂
)old
+ I−1S. (17)
where S is the score vector and I is the expected information matrix based on REML likelihood for
Y c−pseudo. Letting θT = (σ, λ), the expression for the element of score vector and information matrix,
are then given by
Sσ =
1
2
(Y c−pseudo −Uγ̂ − O1)TP δVc
δσ
P (Y c−pseudo −Uγ̂ − O1)− 1
2
tr
(
P
δVc
δσ
)
Sλ =
1
2
(Y c−pseudo −Uγ̂ − O1)TP δVc
δλ
P (Y c−pseudo −Uγ̂ − O1)− 1
2
tr
(
P
δVc
δλ
)
and
Iσλ = −1
2
tr
(
P
δVc
δσ
P
δVc
δλ
)
,
where, P = V −1c − V −1c U(UTV −1c U)−1UTV −1c . The derivatives of Vc with respect to σ and λ are:
δVc
δσ
= 2σR−1λ
δVc
δλ
= σ2R−1λ (R− I)R−1λ ,
where Rλ = (1 − λ)I + λR and R is the intrinsic autoregression matrix determined by neighbourhood
structure . The typical element ofR is given by
Rij =
{
ni, i = j
−I{i ∼ j} i 6= j.
20
Here, ni is the number of neighbours of region i, and I{i ∼ j} is an indicator function indicating whether
regions i and j are neighbours.
Repeated iterations of equations (13)-(17) are carried out, leading to reliable estimates of the region
specific fixed effect and random effect parameters. Convergence is achieved when the changes in parameter
estimates are less than a prespecified tolerance level (less than 1e − 3, in the simulation study reported).
Approximate standard errors for λ and σ are obtained from the above information matrix in the usual way.
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Appendix B: Additional Table
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Table 5: Descriptive analysis of neutropenia data
Variables Neutropenia Total
n (%)
Age (mean± sd) 59.6 (14.3) 64.9 (14.5)
Sex
Female 6,363 (5.0) 127,519
Male 6,298 (4.1) 152,104
Year of Diagnosis
2001 1,343 (4.9) 27,356
2002 1,411 (5.0) 28,451
2003 1,503 (5.1) 29,560
2004 1,478 (4.8) 30,970
2005 1,596 (5.1) 31,533
2006 1,452 (4.6) 31,865
2007 1,453 (4.5) 32,603
2008 1,405 (4.2) 33,343
2009 1,020 (3.0) 33,942
ARIA
Major Cities 9,199 (4.9) 189,322
Inner Regional Australia 2,638 (3.9) 67,086
Outer Regional Australia 774 (3.6) 21,664
Remote or Very remote Australia 50 (3.2) 1,551
Cancer Type
Breast Cancer 2,059 (5.3) 38,620
Lung cancer 1,401 (6.2) 22,744
Colon & rectum cancer 1,011 (3.0) 34,018
Haematological Malignancy 5,134 (25.0) 20,518
Other cancer 3,056 (1.9) 163,723
No. of major comorbidities
0 6,072 (3.7) 163,645
1 2,228 (4.9) 45,817
2 2,315 (6.7) 34,670
3 976 (5.7) 17,264
4+ 1,070 (5.9) 18,227
SEIFA
Most disadvantaged 1,388 (4.6) 30,302
2 1,750 (4.1) 42,558
3 3546 (4.5) 78,006
4 2800 (4.6) 60,880
Least disadvantaged 3177 (4.7) 67,877
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Table 6: Estimated regression coefficients and variance parameters for the proposed smooth-indiCAR
method using NSW as geography and 20000 sample sizes.
True β2 β32 β33 β34 β35 γ σ λ
value -2.00 -1.50 0.15 0.50 0.20 0.20 0.40
λ Estimated coefficient
0.00 -1.988 -1.498 0.146 0.492 0.199 0.205 0.356 0.002
0.25 -1.985 -1.490 0.147 0.496 0.205 0.206 0.369 0.220
0.50 -1.986 -1.488 0.151 0.497 0.204 0.195 0.355 0.405
0.75 -1.992 -1.496 0.113 0.443 0.183 0.201 0.366 0.625
0.99 -1.991 -1.467 0.124 0.445 0.187 0.211 0.378 0.852
Empirical standard error
0.00 0.022 0.057 0.032 0.031 0.031 0.018 0.015 0.016
0.25 0.022 0.059 0.033 0.032 0.032 0.015 0.017 0.049
0.50 0.022 0.058 0.033 0.031 0.032 0.014 0.018 0.079
0.75 0.022 0.058 0.033 0.031 0.031 0.013 0.020 0.101
0.99 0.025 0.064 0.036 0.034 0.035 0.013 0.022 0.079
Average of the simulated standard error
0.00 0.020 0.056 0.029 0.036 0.031 0.011 0.018 0.006
0.25 0.020 0.062 0.030 0.032 0.031 0.009 0.017 0.047
0.50 0.020 0.057 0.030 0.035 0.031 0.009 0.015 0.070
0.75 0.021 0.033 0.018 0.017 0.018 0.010 0.014 0.061
0.99 0.022 0.049 0.025 0.026 0.027 0.010 0.016 0.056
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Appendix C: R Codes
Data simulation
library(MASS)
library(plyr)
library(reshape)
library(mgcv)
DataSimulation<-function(nGroup=400,sigma=0.4,lambda=0.75, beta0=0, beta1=1,
beta2=-2.0, beta32=-1.5,beta33=0.15,beta34=0.5,beta35=0.2, gamma=0.2)
{
# nGroup: Total number of group
# lambda: Spatial range parameters
# sigma: variance parameter
# beta0-beta3: coefficients of individual level covariates
# gamma: coefficient of group level covariates
# Randomly generate number of individuals within a group
repeat{
indivGroup<-as.vector(rmultinom(n=1, size=20000,prob=runif(400,0.05)))
if (all(indivGroup)>=1){break}
}
totalSample<-sum(indivGroup)
#generate covariate values
# Generate x2 as a binary variable to represent sex in the data
pr =runif(totalSample,0.45,0.55)
x2<-rbinom(totalSample,1,pr)
# Generate smooth covariate, f1
x1<-sort(runif(totalSample))
f <-function(x) 1/(1+x) - 2*exp(-20*(x-1.0)ˆ2)
f1<-f(x1)
# Generate categorical variable to represent age group.
x3<-sample(1:5,totalSample, replace=TRUE, prob=c(0.06,0.09,0.19,0.25,0.25))
#generate group level covariate
z2<-rnorm(nGroup)
x4<-rep(z2,indivGroup)
# generate postcode ID’s
ID<-rep(1:nGroup,indivGroup)
# GroupData
GroupData<-as.data.frame(cbind(1:nGroup,z2))
names(GroupData)<-c("ID","x4")
#Generating spatial random effect in a lattice grid
#### Set up a square lattice region
x.easting <- 1:20
x.northing <- 1:20
Grid <- expand.grid(x.easting, x.northing)
n <- nrow(Grid)
#### set up distance and neighbourhood matrices
distance <-array(0, c(n,n))
W <-array(0, c(n,n))
for(i in 1:n)
{
for(j in 1:n)
{
temp <- (Grid[i,1] - Grid[j,1])ˆ2 + (Grid[i,2] - Grid[j,2])ˆ2
distance[i,j] <- sqrt(temp)
if(temp==1) W[i,j] <- 1
}
}
R <- -W
diag(R) <- as.numeric(apply(W, 1, sum))
Sigma.inv<-1/sigmaˆ2*(lambda*R + (1-lambda)*diag(rep(1,n)))
Sigma<-solve(Sigma.inv)
phi <- mvrnorm(n=1, mu=rep(0,n), Sigma=Sigma)
phi_long<-rep(phi,indivGroup)
mu <- exp(beta0 + beta1*f1+beta2*x2+beta32*I(x3==2)+beta33*I(x3==3)+
beta34*I(x3==4)+beta35*I(x3==5)+gamma*x4+phi_long)
#generate Y-values
y <- rpois(totalSample, lambda=mu)
#data set
data <- data.frame(ID,y=y, x1,x2,x3,f1)
output<-list(data=data,R=R,W=W,GroupCovData=GroupData)
output
}
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Implementation of smooth-indiCAR
set.seed(12345)
# Obtain individuallevel data, group level data and adjacency based weight matrices
# Note: In real data analysis these datasets and matrices might come from different
# sources, hence needs to be read in memory using read.table () or similar function
DataSim<-DataSimulation()
# Individual level outcome and covariate data
Data<-DataSim$data
# Obtain Grouplevel data based on simulation
GroupCovData<-DataSim$GroupCovData
# Spatial correlation matrix
R <- DataSim$R
#Use of generalized linear model with individual level covariates
# Fit individual level outcome with individual level covariates
fit_ind<-gam(y˜s(x1,k=10)+x2+as.factor(x3), data=Data,family="poisson")
beta <- coef(fit_ind)
#Calculate the fitted value
Data$Predict<-exp(predict(fit_ind))
#Aggregate data Over postcode
AreaData<-Data[,c("y","ID","Predict")]
aggdata <-aggregate(. ˜ ID, data = AreaData, sum)
nGroup<-nrow(aggdata)
GroupData<-merge(GroupCovData,aggdata,by="ID")
names(GroupData)<-c("ID","x4","totalY","totalePredict")
#Fitting PQL model
gamma.iter<-NULL
theta.iter<-NULL
beta.iter<-NULL
#Set initial values
gamma.hat<-0
b.rand<-rep(0,nGroup)
sigma.hat <-0.5
lambda.hat <-0.5
theta.hat<-c(sigma.hat,lambda.hat)
betaCombined<-c(beta,gamma.hat)
X_group <-as.matrix(GroupData$x4)
Y<-as.matrix(GroupData$totalY)
OffSet<-as.matrix(log(GroupData$totalePredict))
repeat{
repeat{
# Estimate covariance matrices
R.lambda <- lambda.hat*R + (1-lambda.hat)*diag(rep(1,nGroup))
R.lambda.inv<-solve(R.lambda)
D.hat.inv<-1/(sigma.hatˆ2)*R.lambda
D.hat<-solve(D.hat.inv)
# Calculate the PQL elements
repeat{
eta.est<-OffSet+X_group%*%gamma.hat+b.rand
mu.est<-exp(eta.est)
zz.est<-eta.est+(Y-mu.est)/mu.est
W.hat<-diag(as.vector(mu.est))
W.hat.inv<-diag(as.vector(1/mu.est))
#Estimate covariance matrix of Y
V.hat<-W.hat.inv+D.hat
V.hat.inv<-solve(V.hat)
#Estimate the fixed and random effect
gammaUpdate<-solve(t(X_group)%*%V.hat.inv%*%X_group)%*%
(t(X_group)%*%V.hat.inv%*%(zz.est-OffSet))
b.rand.update<-D.hat%*%V.hat.inv%*%(zz.est-OffSet-X_group%*%gammaUpdate)
diff<-abs(gammaUpdate-gamma.hat)
diff.rand<-abs(b.rand.update-b.rand)
gamma.iter<-rbind(gamma.iter,gammaUpdate)
if (all(diff< 1e-5) & all(diff.rand< 1e-3)){break}
gamma.hat<-gammaUpdate
b.rand<-b.rand.update
names(gamma.hat)<-c("gamma")
}
# Extract score and observed information matrix
P<-V.hat.inv-(V.hat.inv%*%X_group%*%solve(t(X_group)%*%V.hat.inv%*%X_group)%*%
t(X_group)%*%V.hat.inv)
dV.sigma<-2*sigma.hat*R.lambda.inv
dV.lambda<--1*sigma.hatˆ2*R.lambda.inv%*%(R-diag(rep(1,nGroup)))%*%R.lambda.inv
#Score vector
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score.sigma<-0.5*(t(zz.est-OffSet-X_group%*%gammaUpdate)%*%P)%*%dV.sigma%*%
(P%*%(zz.est-OffSet-X_group%*%gammaUpdate))-0.5*sum(diag(P%*%dV.sigma))
score.lambda<-0.5*(t(zz.est-OffSet-X_group%*%gammaUpdate)%*%P)%*%dV.lambda%*%
(P%*%(zz.est-OffSet-X_group%*%gammaUpdate))-0.5*sum(diag(P%*%dV.lambda))
score<-c(score.sigma,score.lambda)
exp.inf11<-0.5*sum(diag(P%*%dV.sigma%*%P%*%dV.sigma))
exp.inf12<-0.5*sum(diag(P%*%dV.sigma%*%P%*%dV.lambda))
exp.inf21<-0.5*sum(diag(P%*%dV.lambda%*%P%*%dV.sigma))
exp.inf22<-0.5*sum(diag(P%*%dV.lambda%*%P%*%dV.lambda))
exp.infor<-matrix(c(exp.inf11,exp.inf12,exp.inf21,exp.inf22),ncol=2)
thetaUpdate<-theta.hat+solve(exp.infor)%*%score
if (thetaUpdate[2]>1) {thetaUpdate[2]<-0.99999}
if (thetaUpdate[2]<0) {thetaUpdate[2]<-0.00001}
if (thetaUpdate[1]<0) {thetaUpdate[1]<-0.00001}
sigma.hat<-thetaUpdate[1]
lambda.hat<-thetaUpdate[2]
diff.theta<-abs(thetaUpdate-theta.hat)
theta.iter<-rbind(theta.iter,as.vector(thetaUpdate))
if (all(diff.theta< 1e-5)){break}
theta.hat<-thetaUpdate
names(theta.hat)<-c("sigma","lambda")
}
# Repeat individual level data fitting
GroupData$Predict_group<-X_group%*%gamma.hat+b.rand
combinedData<-merge(Data,GroupData[,c("ID","Predict_group")],by=c("ID"))
fit_ind<-gam(y˜s(x1,k=10)+x2+as.factor(x3),offset=Predict_group,
data=combinedData,family="poisson")
#Calculate the fitted value
betaUpdate<-coef(fit_ind)
#Calculate the fitted value
combinedData$Predict<-exp(predict(fit_ind))
AreaData<-combinedData[,c("y","ID","Predict")]
aggdata <-aggregate(. ˜ ID, data = AreaData, sum)
GroupData<-merge(GroupCovData,aggdata,by="ID")
names(GroupData)<-c("ID","x4","totalY","totalePredict")
Y<-as.matrix(GroupData$totalY)
OffSet<-as.matrix(log(GroupData$totalePredict))
betaCombined.Update<-c(betaUpdate,gamma.hat)
diff.est<-abs(betaCombined.Update-betaCombined)
beta.iter<-rbind(beta.iter,betaCombined.Update)
if (all(diff.est< 1e-5)) {break}
betaCombined<-betaCombined.Update
# End of Our method
}
#Estimation of standard error
# Extract design matrix
G<-gam(y˜s(x1,k=10)+x2+as.factor(x3),offset=Predict_group, fit=FALSE,
data=combinedData,family="poisson")
X_bar<-G$X
#Extract smoothing vector and parameter
lambda<-as.vector(fit_ind$sp)
K<-G$S[[1]]
S<-lambda*K
M<-nGroup
group.size<-as.vector(table(combinedData$ID))
group.cov.long<-data.matrix(X_group[rep(1:nrow(X_group), times = group.size), ])
cov.combined<-cbind(X_bar,group.cov.long)
fitted.combined<-cov.combined%*%betaCombined+rep(b.rand,group.size)
mu.combined<-as.vector(exp(fitted.combined))
Xcov.m<-X_bar*mu.combined
XTWX<-t(Xcov.m)%*%X_bar
groupID<-rep(c(1:M),group.size)
XTWZ<-t(rowsum(Xcov.m, groupID))
XTWZD<-XTWZ%*%D.hat
ZTWZ.vec<-aggregate(mu.combined,by=list(groupID),sum)
ZTWZ<-diag(ZTWZ.vec$x)
ZTWZD<-ZTWZ%*%D.hat
I.ZTWZD<-(diag(M)+ZTWZD)
I.ZTWZD.inv<-solve(I.ZTWZD)
a11<-XTWX-XTWZD%*%I.ZTWZD.inv%*%t(XTWZ)
XTWZU<-XTWZ%*%X_group
ZTWZU<-ZTWZ%*%X_group
a12<-XTWZU-XTWZD%*%I.ZTWZD.inv%*%ZTWZU
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a21<-t(a12)
a22<-t(X_group)%*%ZTWZ%*%X_group-t(X_group)%*%ZTWZ%*%D.hat%*%
I.ZTWZD.inv%*%ZTWZ%*%X_group
Q.inv<-as.matrix(rbind(cbind(a11,a12),cbind(a21,a22)))
Q<-solve(Q.inv)
se.coef<-sqrt(diag(Q))
# Frequentist (se.Freq) and Bayesian standard error (se.Bayes)
S1<-matrix(0,ncol(Q.inv),ncol(Q.inv))
S1[7:15,7:15]<-S
Q_penalty.inv<-Q.inv+S1
Bayes.var<-solve(Q.inv+S1)
se.Bayes<-sqrt(diag(Bayes.var))
Freq.var<-Bayes.var%*%Q.inv%*%Bayes.var
se.Freq<-sqrt(diag(Freq.var))
#Calculate standard error for non-linear function
var.basis.freq<-Freq.var[7:15,7:15]
var.basis.Bayes<-Bayes.var[7:15,7:15]
basis<-G$X[,7:15]
eta.hat<-as.vector(betaCombined[7:15])
f.est<-mean(combinedData$f1)+as.vector(basis%*%eta.hat)
var.Freq.f<-rowSums((basis%*%var.basis.freq)*basis)
var.Bayes.f<-rowSums((basis%*%var.basis.Bayes)*basis)
seFreq.f<-sqrt(var.Freq.f)
seBayes.f<-sqrt(var.Bayes.f)
# Calculate standard error of spatial random effect parameters
se.theta<-sqrt(diag(solve(exp.infor)))
# Combine all the estimated parameters
# betaCombined: Parameters for fixed effect coefficients
#(both individual and group level) and spline coefficients
# theta.hat: Spatial random effect parameters
coef<-c(betaCombined,theta.hat)
se.coef.all<--c(se.coef,se.Freq,se.Bayes,se.theta)
f.hat<-f.est
seFreqf.hat<-seFreq.f
seBayesf.hat<-seBayes.f
#***********************************************#
# Final Output #
#***********************************************#
output<-list(coef=coef,se.coef=se.coef.all,f.hat=f.hat,
seBayes.f=seBayesf.hat,seFreq.f=seFreqf.hat)
output$coef
output$se.coef
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